Evaluation of the parathyroid function in six patients with hypophosphatemic osteomalacia, including a case of tertiary hyperparathyroidism developing during combined oral phosphate and vitamin D therapy

Hormone Research

Volumn 60, Issue 3, 2003, Pages 127-133

  Jeon, Hyun Jeong ^b   Kwon, Seong Hee ^b   Kim, Sang Wan ^b   Shin, Chan Soo ^b   Park, Kyung Soo ^b   Kim, Seong Yeon ^a   Cho, Bo Yeon ^b   Lee, Hong Kyu ^b  

^a Seoul National University Hospital   (South Korea)

^b NONE

Author keywords

Hyperparathyroidism; Hypophosphatemic osteomalacia

Indexed keywords

CALCIUM; PHOSPHATE; TECHNETIUM 99M; VITAMIN D;

ADENOMA; ADULT; ARTICLE; BIOCHEMISTRY; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EVALUATION; FEMALE; HISTOLOGY; HUMAN; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; MALE; OSTEOMALACIA; PARATHYROID FUNCTION; PARATHYROID GLAND; PARATHYROIDECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; OSTEOMALACIA; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHATES; VITAMIN D;

EID: 0042386236     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072524     Document Type: Article

References (20)

1. Firth RG, Grant CS, Riggs B: Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia: Report of two cases. Am J Med 1985;78:669-673.
2. Glorieux FH, Marie PJ, Pettifor JM, Dvelin EE: Bone response to phosphate salts, ergocalciferol and calcitriol in familial hypophosphatemic rickets. N Engl J Med 1980;303:1023-1031.
3. Bettinelli A, Bianchi ML, Mazzucchi E, Gandolini G, Appiani AC: Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. J Pediatr 1991;118:372-376.
4. Amud CD, Glorieux F, Scriver C: Serum parathyroid hormone in X-linked hypophosphatemia. Science 1971;173:845-847.
5. Hahn TJ, Schrap CR, Halstead LR, Haddad JG, Karl DM, Avioli LV: Parathyroid hormone status and renal responsiveness in familial hypophosphatemic rickets. J Clin Endocrinol Metab 1975;41:926-937.
6. Scott AR, Ghada E, Edward MB, John DC: Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 1992;75:1514-1518.
7. Vedere V, Goupille P, Valat JP, Lecomte P: Tertiary hyperparathyroidism induced by the treatment of hypophosphatemic osteomalacia. Ann Endocrinol (Paris) 1996;57:215-218.
8. Reid IR, Teitelbaum SL, Dusso A, Whyte MP: Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia: Effect of successful tumor resection on mineral homeostasis. Am J Med 1987;83:350-354.
9. Knudtzon J, Halse J, Monn E, Nesland A, Nordal KP, Paus P, Selp M, Sund S, Sodal G: Autonomous hyperparathyroidism in X-linked hypophosphatemia. Clin Endocrinol (Oxf) 1995;42:199-203.
10. Narvaez J, Rodriguez-Moreno J, Moragues C, Campoy E, Clavaguera T, Roig-Escofet D: Tertiary hyperparathyroidism after long-term phosphate supplementation in adult-onset hypophosphataemic osteomalacia. Br J Rheumatol 1996;35:598-600.
11. Henneman PH, Dempsey EF, Carroll EL, Henneman DH: Acquired vitamin D resistant osteomalacia: A new variety characterized by hypercalcemia, low serum bicarbonate, and hyperglycinuria. Metabolism 1962;11:103-116.
12. Edelson G, Shih MS, Parfitt AM: A unique case of adult hypophosphate osteomalacia. Bone 1993;14:707-710.
13. Walton RJ, Bijvoet OL: Nomogram for derivation of renal threshold phosphate concentration. Lancet 1975;ii:309-310.
14. Balsan S, Tieder M: Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: Influence of treatment regimen and parental height. J Pediatr 1990;116:365-371.
15. 3. Pediatrics 1980;66:445-454.
16. Hebert LA, Lemann J Jr, Petersen JR, Lennon EJ: Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest 1966;45:1886-1894.
17. 3 on tubular handling of phosphate in hypophosphatemic rickets. J Clin Endocrinol Metab 1994;58:671-674.
18. Schapira D, Ben Izhak O, Nachtigal A, Burstein A, Shalom RB, Shagrawi I, Best LA: Tumor-induced osteomalacia. Semin Arthritis Rheum 1995;25:35-46.
19. Harvey JN, Gray C, Belchetz PE: Oncogenous osteomalacia and malignancy. Clin Endocrinol (Oxf) 1992;37:379-382.
20. Huang QL, Feig DS, Blackstein ME: Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia. J Endocrinol Invest 2000;23:263-267.